| Valuation method | Value, CHF | Upside, % |
|---|---|---|
| Artificial intelligence (AI) | 18.29 | 34 |
| Intrinsic value (DCF) | 7.06 | -48 |
| Graham-Dodd Method | 6.14 | -55 |
| Graham Formula | n/a |
Aevis Victoria SA is a diversified Swiss company operating in healthcare, hospitality, lifestyle, and infrastructure sectors. Headquartered in Fribourg, Switzerland, the company is a subsidiary of M.R.S.I. Medical Research, Services and Investments S.A. Aevis Victoria operates 22 hospitals with 1,496 beds, making it a significant player in Switzerland's healthcare sector. Additionally, the company manages hospitality assets with 941 rooms and a rentable surface of 188,109 sqm. Beyond traditional healthcare, Aevis Victoria provides telemedicine, ambulance services, and day clinic operations. The company also engages in patient hotels, better aging solutions, radiology, pharmacy, ophthalmology, real estate management, stem cell research, cosmetics, and publishing. With a strong presence in Switzerland, Aevis Victoria combines healthcare expertise with lifestyle and infrastructure investments, positioning itself as a unique player in the Swiss market.
Aevis Victoria SA presents a mixed investment profile. The company operates in stable sectors like healthcare and hospitality, which benefit from Switzerland's strong economy and aging population. However, its financials show challenges, with a net loss of CHF 2.87 million in the latest fiscal year and negative diluted EPS of CHF -0.03. The company has a high total debt of CHF 1.07 billion against cash reserves of CHF 36.88 million, raising concerns about leverage. On the positive side, Aevis Victoria generates CHF 101.04 million in revenue and maintains a diversified business model across healthcare and hospitality. The stock's beta of -0.155 suggests low correlation with broader market movements, which could appeal to risk-averse investors. Given its mixed financial performance, investors should weigh the company's sector diversification against its debt load and profitability challenges.
Aevis Victoria SA holds a unique position in the Swiss market by combining healthcare, hospitality, and infrastructure under one corporate umbrella. Its competitive advantage stems from its extensive hospital network (22 facilities) and integrated healthcare services, including telemedicine and specialized clinics. The company's diversification into hospitality (patient hotels) and lifestyle services provides additional revenue streams that pure-play healthcare providers lack. However, Aevis Victoria faces competition from specialized healthcare providers and larger hospital operators in Switzerland. Its real estate holdings provide asset backing but may also tie up capital that could be deployed more efficiently. The company's negative beta suggests it operates somewhat independently of market cycles, which could be advantageous in economic downturns. Challenges include high debt levels and the capital-intensive nature of its hospital operations. Aevis Victoria's subsidiary structure under M.R.S.I. Medical Research provides potential synergies in medical research and innovation, though this relationship may also create complexity. The company's ability to integrate its diverse business lines will be key to maintaining its competitive edge.